Equine leucocyte antigen system. III. Non-MHC linked alloantigenic system in horses.

The study discusses a newly discovered alloantigenic membrane antigen on horse lymphocytes, not linked to the major histocompatibility complex (MHC). This antigen, dubbed ELy-1, appears in about half of the sampled horse population and may be associated with chronic bronchitis and laminitis.

Discovery of ELy-1 Antigen

• Researchers have identified a new antigen on the lymphocytes of equines known as ELy-1.
• This antigen was distinguished by using alloantisera in a two-stage microcytotoxicity test.
• Unlike other known antigens on horse lymphocytes, the ELy-1 antigen is not linked to the major histocompatibility complex (MHC).

Prevalence of ELy-1 Antigen

• Extensive testing shows that roughly 50% of horses across various populations are positive for the ELy-1 antigen.

Genetic Influence and Expression

• The genetic inheritance pattern of ELy-1 is autosomal dominant.
• The researchers hypothesize that there are only two possible allele outcomes for this antigen: ELy-1+ and ELy-1-.
• They concluded this after carrying out several family studies in which they failed to demonstrate any allelic antigen.
• In horses testing positive for ELy-1, the antigen was expressed on both T and B lymphocytes.
• However, the ELy-1 antigen did not show up on erythrocytes and thrombocytes.

Health Implications

• The study also detected a noteworthy trend relating to horse health status.
• It was found that the frequency of ELy-1 positivity was significantly higher in groups of horses suffering from chronic bronchitis or laminitis when compared to clinically healthy control groups.
• This suggests the antigen could have some links with these health complications, although the nature of these potential links is not explored in the study.